DR. CHARLES INMAN WILMER, MD

ATLANTA, GA

Research Active
Internal Medicine - Interventional Cardiology NPI registered 21+ years 11 publications 1995 – 2021 NPI: 1942205224
Reproducibility of ResultsPrognosisTomography, X-Ray ComputedImaging, Three-DimensionalSeverity of Illness IndexCoronary AngiographyCoronary Artery DiseaseAdministration, OralFibrosisMyocardial InfarctionPredictive Value of TestsUltrasonography, InterventionalGeorgiaNecrosisScattering, Radiation

Practice Location

275 COLLIER RD NW
ATLANTA, GA 30309-1709

Phone: (404) 605-2800

What does CHARLES WILMER research?

Dr. Wilmer studies the effectiveness of various treatments and diagnostic methods for heart-related conditions and asthma management. His work involves examining how frequently certain medications, like oral corticosteroids, are prescribed to asthma patients and evaluating the effectiveness of advanced imaging techniques in assessing heart artery blockages. Dr. Wilmer also investigates how new treatment protocols can lead to better outcomes for diabetic patients dealing with heart problems, as well as how climate change affects ecosystems that depend on snow.

Key findings

  • In a study of asthma patients, 9% were prescribed oral corticosteroids for over 30 days annually, with the rate rising to 14% for patients over 65, indicating a need for safer treatment options.
  • Research showed that quantitative coronary angiography accurately predicted blood flow issues in narrowed arteries, achieving 95% sensitivity and 82% specificity when compared to the standard fractional flow reserve test.
  • Plaques in heart arteries linked to major adverse events were found to be 65% larger and had 6.6% less dense calcium compared to those not associated with such events, highlighting the importance of plaque characteristics in predicting heart attacks or strokes.
  • Patients with in-stent restenosis who received vascular brachytherapy had significantly lower rates of re-narrowing (19.4%) compared to those receiving standard treatment (37.3%), suggesting this method is beneficial for diabetic heart patients.
  • Long-term use of clopidogrel after a coronary intervention reduced the combined risk of death, heart attack, or stroke by about 27% compared to not using it, despite a slight increase in the risk of major bleeding.

Frequently asked questions

Does Dr. Wilmer study asthma?
Yes, Dr. Wilmer examines prescription trends and treatment options for asthma, focusing on the implications of long-term use of oral corticosteroids.
What treatments has Dr. Wilmer researched for heart disease?
He has researched various treatments including vascular brachytherapy for patients with narrowed arteries and the effects of long-term antiplatelet therapy after coronary procedures.
Is Dr. Wilmer's work relevant to diabetic patients?
Yes, his studies specifically look at how treatments can benefit diabetic patients with heart issues, demonstrating effective approaches for this group.
What imaging techniques does Dr. Wilmer use in his research?
He utilizes techniques like quantitative coronary angiography, computed tomography angiography, and intravascular ultrasound to assess heart conditions.
How does climate change relate to Dr. Wilmer's research?
He has developed methods to simulate the impacts of climate change on snowmelt, which helps researchers understand its effects on ecosystems dependent on snow.

Publications in plain English

Oral corticosteroid prescription for asthma by general practitioners: A three-year analysis in Germany.

2021

Respiratory medicine

Lommatzsch M, Sauerbeck IS, Wilmer C, Taube C

Plain English
This study looked at how often general practitioners in Germany prescribe oral corticosteroids (OCS) for asthma patients over three years, examining records from around 30,000 patients. It found that 9% of patients received these medications for over 30 days each year, with the rate being higher (about 14%) in those over 65. The findings highlight that many asthma patients are still being treated with a medication that can have serious side effects, even when there are safer options available. Who this helps: This helps patients with asthma and their doctors by emphasizing the need for safer treatment choices.

PubMed

Accelerated Snowmelt Protocol to Simulate Climate Change Induced Impacts on Snowpack Dependent Ecosystems.

2020

Bio-protocol

Leonard LT, Wilmer C, Steltzer H, Williams KH, Sharp JO

Plain English
This study focuses on how changing climate patterns affect snowmelt, which is crucial for ecosystems that rely on snow. Researchers developed a simple and low-cost method to speed up snowmelt by using a special fabric that increases sunlight absorption on the snow surface. They found that this method can make snow melt 14 to 23 days earlier, mimicking conditions in warmer locations, which helps scientists understand the broader impacts of climate change on these ecosystems. Who this helps: This benefits researchers studying climate change effects on snow-dependent ecosystems.

PubMed

MOFs modeling and theory: general discussion.

2017

Faraday discussions

Addicoat M, Butler K, Farha O, Gagliardi L, Hajiahmadi Farmahini A +17 more

PubMed

Prospective, head-to-head comparison of quantitative coronary angiography, quantitative computed tomography angiography, and intravascular ultrasound for the prediction of hemodynamic significance in intermediate and severe lesions, using fractional flow reserve as reference standard (from the ATLANTA I and II Study).

2014

The American journal of cardiology

Voros S, Rinehart S, Vazquez-Figueroa JG, Kalynych A, Karmpaliotis D +8 more

Plain English
This study compared three imaging methods—quantitative coronary angiography (QCA), coronary computed tomography angiography (CTA), and intravascular ultrasound (IVUS)—to see which best predicts blood flow issues in narrowed heart arteries. Researchers looked at 85 patients and found that QCA was the most accurate method, strongly correlating with results from a standard test called fractional flow reserve (FFR). Specifically, QCA showed a strong correlation with FFR and had a high accuracy rate of 95% sensitivity and 82% specificity. Who this helps: Patients with heart artery blockages, as doctors can use these findings to better assess and treat their conditions.

PubMed

Prospective validation that vulnerable plaque associated with major adverse outcomes have larger plaque volume, less dense calcium, and more non-calcified plaque by quantitative, three-dimensional measurements using intravascular ultrasound with radiofrequency backscatter analysis : results from the ATLANTA I Study.

2013

Journal of cardiovascular translational research

Vazquez-Figueroa JG, Rinehart S, Qian Z, Joshi PH, Sharma A +11 more

Plain English
Researchers studied heart artery plaques in 60 patients to see how certain characteristics of these plaques might predict major heart problems (like heart attacks or strokes) over a year. They found that plaques linked to these serious issues were larger and had less dense calcium than those that didn't lead to problems—specifically, the plaque volume was 65% versus 53%, with less dense calcium at 6.6% compared to 14.7%. This understanding helps doctors identify which plaques are more dangerous, allowing for better patient monitoring and treatment decisions. Who this helps: This helps patients at risk for heart diseases and their doctors.

PubMed

Prospective validation of standardized, 3-dimensional, quantitative coronary computed tomographic plaque measurements using radiofrequency backscatter intravascular ultrasound as reference standard in intermediate coronary arterial lesions: results from the ATLANTA (assessment of tissue characteristics, lesion morphology, and hemodynamics by angiography with fractional flow reserve, intravascular ultrasound and virtual histology, and noninvasive computed tomography in atherosclerotic plaques) I study.

2011

JACC. Cardiovascular interventions

Voros S, Rinehart S, Qian Z, Vazquez G, Anderson H +8 more

Plain English
This study looked at how well three-dimensional measurements of coronary artery plaque from a CT scan match up with detailed images from a different ultrasound technique called IVUS. The researchers examined 60 patients and found that while there was a good amount of agreement between the two methods, there were notable differences: for example, the CT scan underestimated the size of the artery's opening by 21%. These findings are important because they show that while CT scans can provide valuable information about plaque, they may not always be accurate, especially in measuring critical details. Who this helps: This benefits doctors by providing insights into the best ways to assess heart disease risk in patients.

PubMed

Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population.

2010

Pharmacoepidemiology and drug safety

Wahl PM, Rodgers K, Schneeweiss S, Gage BF, Butler J +7 more

Plain English
This study looked at how well insurance claims codes identify serious health issues like heart attacks, strokes, and severe bleeding in the stomach among patients taking certain pain medications from 2002 to 2004. The researchers found that the claims codes accurately identified heart attacks 88% of the time and strokes 87% of the time, but were less reliable for severe stomach bleeding at 57%. Improving the codes for strokes and stomach bleeding raised their accuracy to 96% and 88%, respectively. This matters because accurate tracking of these events can help in monitoring drug safety and patient well-being. Who this helps: This helps doctors and healthcare researchers monitoring the safety of pain medications.

PubMed

Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes.

2003

International journal of radiation oncology, biology, physics

Suntharalingam M, Laskey WK, Tantibhedhyangkul W, Lansky A, Teirstein P +7 more

Plain English
This study looked at how effective a special type of treatment called vascular brachytherapy (VBT) is for helping diabetic patients who have narrowing in their coronary arteries after getting a stent. It found that, at 8 months after treatment, diabetic patients who received VBT had lower rates of needing further procedures (10.9% for VBT vs. 22.7% for standard treatment) and less re-narrowing of treated arteries (19.4% for VBT vs. 37.3% for standard treatment). This is important because it shows that diabetic patients can benefit from VBT just as much as non-diabetic patients when dealing with artery re-narrowing. Who this helps: This helps diabetic patients with heart issues and their doctors.

PubMed

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

2002

JAMA

Steinhubl SR, Berger PB, Mann JT, Fry ET, DeLago A +3 more

Plain English
This study looked at the effects of long-term clopidogrel treatment, in addition to aspirin, after a procedure called percutaneous coronary intervention (PCI), which helps open blocked heart arteries. Researchers found that taking clopidogrel for a year after PCI reduced the risk of dying, having a heart attack, or experiencing a stroke by about 27% compared to those who didn't take it long-term, while the timing of a loading dose before the procedure had some effects based on how far in advance it was given. Additionally, there was a slight increase in the risk of major bleeding for those who took clopidogrel, but it wasn't definitive. Who this helps: This benefits patients undergoing PCI by potentially improving their long-term heart health.

PubMed

The portrayal of optometry in the media.

1996

Journal of the American Optometric Association

Harris MG, Wilmer C, Saavedra R, Yu S

PubMed

"A stitch in time"--for the heart attack patient.

1995

Journal of the Medical Association of Georgia

Collentine T, Collier MJ, Crews T, Davis W, Morris D +3 more

PubMed

Frequent Co-Authors

Szilard Voros Sarah Rinehart Anna Kalynych Dimitri Karmpaliotis Zhen Qian Hunt Anderson Laura Murrieta Harold Carlson William Ballard Charles Brown

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.